7-140808351-CAAAAAAAAAAAAAAAA-CA

Variant summary

Our verdict is . The variant received -8 ACMG points: 0P and 8B. BS1BS2

The NM_004333.6(BRAF):​c.609-304_609-290delTTTTTTTTTTTTTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000051 in 156,976 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene BRAF is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: not found (cov: 21)
Exomes 𝑓: 0.000051 ( 0 hom. )

Consequence

BRAF
NM_004333.6 intron

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.67

Publications

1 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • large congenital melanocytic nevus
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004333.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.000051 (8/156976) while in subpopulation SAS AF = 0.000236 (7/29638). AF 95% confidence interval is 0.000111. There are 0 homozygotes in GnomAdExome4. There are 6 alleles in the male GnomAdExome4 subpopulation. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 8 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004333.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.609-304_609-290delTTTTTTTTTTTTTTT
intron
N/ANP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.609-304_609-290delTTTTTTTTTTTTTTT
intron
N/ANP_004324.2
BRAF
NM_001374244.1
c.609-304_609-290delTTTTTTTTTTTTTTT
intron
N/ANP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.609-304_609-290delTTTTTTTTTTTTTTT
intron
N/AENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.609-304_609-290delTTTTTTTTTTTTTTT
intron
N/AENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.609-304_609-290delTTTTTTTTTTTTTTT
intron
N/AENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
Cov.:
21
GnomAD4 exome
AF:
0.0000510
AC:
8
AN:
156976
Hom.:
0
AF XY:
0.0000650
AC XY:
6
AN XY:
92296
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
3010
American (AMR)
AF:
0.000132
AC:
1
AN:
7598
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4278
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5104
South Asian (SAS)
AF:
0.000236
AC:
7
AN:
29638
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6736
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
614
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
92786
Other (OTH)
AF:
0.00
AC:
0
AN:
7212
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.613
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
21
Alfa
AF:
0.00
Hom.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.7

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.